Meal and oral glucose tests for assessment of beta -cell function: modeling analysis in normal subjects.
about
Assessment of pancreatic β-cell function: review of methods and clinical applicationsEarly metabolic markers of the development of dysglycemia and type 2 diabetes and their physiological significanceA bio-inspired glucose controller based on pancreatic β-cell physiologyDiabetes: Models, Signals, and Control.A local glucose-and oxygen concentration-based insulin secretion model for pancreatic isletsMechanisms of the incretin effect in subjects with normal glucose tolerance and patients with type 2 diabetes.Predictive performance for population models using stochastic differential equations applied on data from an oral glucose tolerance test.Associations of Dietary Glucose, Fructose, and Sucrose with β-Cell Function, Insulin Sensitivity, and Type 2 Diabetes in the Maastricht Study.One-hour plasma glucose identifies insulin resistance and beta-cell dysfunction in individuals with normal glucose tolerance: cross-sectional data from the Relationship between Insulin Sensitivity and Cardiovascular Risk (RISC) study.Altered islet function and insulin clearance cause hyperinsulinemia in gastric bypass patients with symptoms of postprandial hypoglycemiaEating two larger meals a day (breakfast and lunch) is more effective than six smaller meals in a reduced-energy regimen for patients with type 2 diabetes: a randomised crossover studyA model of GLP-1 action on insulin secretion in nondiabetic subjects.The oral minimal model method.β-cell function, incretin effect, and incretin hormones in obese youth along the span of glucose tolerance from normal to prediabetes to type 2 diabetes.The heritability of beta cell function parameters in a mixed meal test design.Parental history of type 2 diabetes, TCF7L2 variant and lower insulin secretion are associated with incident hypertension. Data from the DESIR and RISC cohorts.Body weight, not insulin sensitivity or secretion, may predict spontaneous weight changes in nondiabetic and prediabetic subjects: the RISC study.Postdinner resistance exercise improves postprandial risk factors more effectively than predinner resistance exercise in patients with type 2 diabetes.Insulin response to oral stimuli and glucose effectiveness increased in neuroglycopenia following gastric bypassInfluence of hyperinsulinemia and insulin resistance on in vivo β-cell function: their role in human β-cell dysfunction.Adaptation of β-Cell and Endothelial Function to Carbohydrate Loading: Influence of Insulin ResistanceGlucose Homeostatic Law: Insulin Clearance Predicts the Progression of Glucose Intolerance in Humans.Impact of family history of diabetes on β-cell function and insulin resistance among Chinese with normal glucose toleranceEffects of bariatric surgery on glucose homeostasis and type 2 diabetesModel-Based Quantification of Glucagon-Like Peptide-1-Induced Potentiation of Insulin Secretion in Response to a Mixed Meal Challenge.The potential role of sodium glucose co-transporter 2 inhibitors in the early treatment of type 2 diabetes mellitusAssessment of beta-cell function in humans, simultaneously with insulin sensitivity and hepatic extraction, from intravenous and oral glucose tests.Influence of maternal obesity on insulin sensitivity and secretion in offspringNonalcoholic Steatohepatitis (NASH) Is Associated with a Decline in Pancreatic Beta Cell (β-Cell) Function.Metabolic effects of chronic cannabis smokingBeta-cell function assessment from modelling of oral tests: an effective approach.Novel insights into glucocorticoid-mediated diabetogenic effects: towards expansion of therapeutic options?A Novel Insulin/Glucose Model after a Mixed-Meal Test in Patients with Type 1 Diabetes on Insulin Pump Therapy.Metabolic response to sodium-glucose cotransporter 2 inhibition in type 2 diabetic patients.Blockade of glucagon-like peptide 1 receptor corrects postprandial hypoglycemia after gastric bypass.Effects of leptin replacement therapy on pancreatic β-cell function in patients with lipodystrophy.Canagliflozin, a sodium glucose co-transporter 2 inhibitor, improves model-based indices of beta cell function in patients with type 2 diabetes.Modeling of 24-hour glucose and insulin profiles of patients with type 2 diabetes.Classification and functions of enteroendocrine cells of the lower gastrointestinal tract.Clinical pharmacokinetics and pharmacodynamics of vildagliptin.
P2860
Q26829445-03D8F79E-EE77-49F8-B51F-04EEF978A1D2Q28279396-0B5815D2-B371-4306-B5AE-347FFEF028EBQ30419609-BB6C0AB6-EDAA-4EEA-993F-A72084D8090CQ30434551-F4436FFD-B72A-4DA5-AD65-CA4913698278Q30502561-CB94D33A-212F-4475-8CD6-2E89B5445BB4Q31137356-FE2E7FEF-DC00-4979-A657-9E1DE49A6AB7Q33518699-67B27729-CE51-4D22-AE77-39F0D4C76672Q33616844-EE176A90-6F2B-454B-A637-95770A014495Q33678580-638F65DB-A5AC-4452-9216-295E5D9F3298Q33682506-B07FA07F-266C-45AA-AD7E-3819CEFC9CB1Q33839305-2D9261CB-CC5A-4BEC-99A7-2BC2F0755BAEQ33916585-C2BD71AB-E249-43EB-8F51-DA97C97A13EBQ34263966-54DA6437-0AA9-41ED-8CC3-D7140B45EDB2Q34393402-8567DA0B-2EF6-47C4-8D90-2ACA7CF0B5EFQ34768527-AD915DDD-7D0C-4667-9BD6-09A1A18517FDQ34940230-23D52C25-561E-46F2-A514-60B3D663E366Q35063254-16592594-6487-41BE-A5B3-746C22ED51DDQ35138480-03400D80-EE0A-47CE-BEDD-9B57EB693A32Q35236444-AD4AA020-FF27-466C-AE24-35D0EC4AF87CQ35561076-E31B5459-A50B-4D2D-8B6C-F264C2469D8CQ35769553-3965060F-B717-4E40-AA4D-36BEE3F5AEE2Q35856775-2136CBB9-0079-4D70-9C32-807532BF4292Q35986206-F04532CD-8062-496D-8D12-1EF4BD28D079Q36292243-D6860022-11CE-4EED-B5C8-53CBEE66E40BQ36475938-15095952-C2D1-4D25-8291-1015C5D63442Q36592820-613A3C1B-F502-484B-8CEC-10C57359FB2DQ36753104-3C93DB0E-DCE2-47AE-9CCD-C385D0443D0FQ36842114-50822888-4644-4E50-A81A-5920C1AA75D1Q36987281-7F8F91A6-6EF4-4DC6-A503-71119F19E46EQ37022702-9EAC901A-F5F6-46F2-8942-F4EF93B66F6FQ37286297-74F999D9-945A-4334-9E19-3F42B5B45A95Q37387727-74BA435A-E953-4477-A212-6ABDD207F035Q37400145-F2810364-3F0D-4EB3-88DD-18977A62C3BBQ37524302-30DCEDD9-206D-4749-927D-58FA2D753ACDQ37620091-7D457348-CE06-44FB-93D3-8C57E7506450Q37660902-03F1B3DC-6FDE-41D7-9135-B60DD2A6779BQ37692849-EAF057C1-FF97-48A4-BBA9-33AD0337C37CQ37706883-E1A2044A-49E9-4BB1-B0E0-022935CF108EQ37868714-1F003925-6266-4910-B6F2-32659953FA33Q37984567-97D9AC91-B01C-4C64-BEFE-F3526BD62E5B
P2860
Meal and oral glucose tests for assessment of beta -cell function: modeling analysis in normal subjects.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Meal and oral glucose tests fo ...... g analysis in normal subjects.
@en
Meal and oral glucose tests fo ...... g analysis in normal subjects.
@nl
type
label
Meal and oral glucose tests fo ...... g analysis in normal subjects.
@en
Meal and oral glucose tests fo ...... g analysis in normal subjects.
@nl
prefLabel
Meal and oral glucose tests fo ...... g analysis in normal subjects.
@en
Meal and oral glucose tests fo ...... g analysis in normal subjects.
@nl
P2093
P2860
P1476
Meal and oral glucose tests fo ...... g analysis in normal subjects.
@en
P2093
Amalia Gastaldelli
Andrea Mari
Birgit Nyholm
Ele Ferrannini
Ole Schmitz
Torben Oestergaard
P2860
P304
P356
10.1152/AJPENDO.00093.2002
P577
2002-08-06T00:00:00Z